MoveDMD (R): Positive Effects of Edasalonexent, an NF-kappa B Inhibitor, in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy in Phase 2 Study with an Open-Label Extension-MedSci.cn

MoveDMD (R): Positive Effects of Edasalonexent, an NF-kappa B Inhibitor, in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy in Phase 2 Study with an Open-Label Extension

Finkel, R; Vandenborne, KHE; Sweeney, HL; Finanger, E; Tennekoon, G; Shieh, P; Willcocks, RJ; Forbes, SC; Triplett, W; Yum, S; Mancini, M; Fretzen, A; Donovan, J

NEUROLOGY, 2018; 90 ():

科室
- - 订阅+
  - 更多科室
工具
服务